Creon DR 36,000 unit capsule UU 100S
Ended Awarded Last action
- Contract number
- SPE2DR26FBGH3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,784
Award facts
- Contract value 100% obligated
- $27,783.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $27,783.78 to AmerisourceBergen Drug Corp for the supply of Creon (pancrelipase) 36,000 unit capsules in 100-count bottles. The contract was competitively awarded without set-aside designation on January 8, 2026, with an ultimate completion date of January 9, 2026. The work will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's parent company, Cencora, Inc.'s, substantial Indefinite Delivery Contract with DLA Troop Support Medical valued at $999.9 million through December 31, 2031, which serves as the primary vehicle for pharmaceutical and medical supply procurement across military healthcare systems globally.
AmerisourceBergen is a major pharmaceutical distributor and critical vendor in the federal medical procurement supply chain, specializing in delivering prescription medications, generic drugs, vaccines, medical devices, and specialized healthcare commodities to military and veteran healthcare systems. As a firm fixed-price delivery order under the broader IDC, this contract award reflects the company's established capability to efficiently fulfill government pharmaceutical requirements. The contract structure and pricing approach are consistent with DLA's standard procurement methodology for essential medical commodities supporting military treatment facilities and federal healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DR26FBGH3?
SPE2DR26FBGH3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 8, 2026.
How much is contract SPE2DR26FBGH3 worth?
The government has obligated $27,784 on SPE2DR26FBGH3.
Is contract SPE2DR26FBGH3 an order under another contract?
Yes. SPE2DR26FBGH3 is a delivery order under SPE2DR25D2001, an indefinite delivery contract.
Was contract SPE2DR26FBGH3 competed?
The extent of competition for SPE2DR26FBGH3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award